Engineering Precision Medicine For The 21st Century (THT Phase 2)

Project: Research

Project Details

Description

This project will bring together scientists from the traditionally separate fields of quantum physics and pharmaceutical chemistry with biomedical engineers and clinicians to develop a radically new approach to precision medicine, based on targeted activation of photosensitive drugs using the light generated by ultrasonically stimulated bubbles.
StatusActive
Effective start/end date1/06/2331/05/28

Collaborative partners

  • University of Oxford (lead)

Funding

  • Engineering and Physical Sciences Research Council: £874,091.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.